In the brains of patients with AD, the mRNA levels of BACE1, which contributes to the development of AD, are reduced in the cortex, dorsal hippocampus, and ventral hippocampus, but not in the cerebellum [26,122]. This evidence concerns the gene BACE1 and Alzheimer disease.